Logo do repositório

Respiratory Vaccines in Older Adults: A Bibliometric Analysis and Future Research Agenda

dc.contributor.authorParodi, Jose F.
dc.contributor.authorRunzer-Colmenares, Fernando
dc.contributor.authorCano-Gutiérrez, Carlos
dc.contributor.authorDinamarca-Montecinos, José Luis
dc.contributor.authorTorre, Patricio Bendía-Gomez de La
dc.contributor.authorVillas Boas, Paulo Fortes [UNESP]
dc.contributor.authorFlores-Cohaila, Javier
dc.contributor.authorUrrunaga-Pastor, Diego
dc.contributor.authorGutiérrez-Robledo, Luis Miguel
dc.contributor.institutionAcademia Latinoamericana de Medicina del Adulto Mayor—ALMA
dc.contributor.institutionUniversidad de San Martín de Porres
dc.contributor.institutionUniversidad Científica del Sur
dc.contributor.institutionPontifica Universidad de Javeriana
dc.contributor.institutionUniversidad de Valparaíso
dc.contributor.institutionPontificia Universidad Católica del Ecuador
dc.contributor.institutionUniversidade Estadual Paulista (UNESP)
dc.contributor.institutionInstituto Nacional de Geriatría
dc.date.accessioned2025-04-29T18:37:14Z
dc.date.issued2025-03-01
dc.description.abstractBackground/Objectives: Respiratory infections impact older adults due to immunosenescence and comorbidities, resulting in increased healthcare costs and mortality. While vaccination is a critical preventive measure, research on respiratory vaccines in older adults in Latin America and the Caribbean (LAC) remains underexplored. This study aims to map the research landscape and identify emerging themes to guide future studies. Methods: A bibliometric analysis was conducted using the Web of Science database, focusing on publications up to 2023 related to respiratory vaccines in LAC’s older adult population. PRISMA-ScR guidelines were followed for data extraction and analysis, with performance metrics and scientometric mapping conducted using Biblioshiny 4.1 and VOSviewer. Results: Ninety-nine studies spanning forty-one journals and 575 authors were included. Brazil contributed 70% of publications, followed by Mexico and Argentina. Influenza and pneumococcal vaccines were the most studied, focusing on coverage, acceptance, and cost-effectiveness. Emerging themes included COVID-19 vaccine effectiveness and vaccination-associated factors. Brazil was identified as the primary hub for collaboration across the region, while other countries made limited contributions. Conclusions: The findings highlight disparities in research output, with Brazil dominating and significant gaps in other LAC countries. Future research should prioritize genomic studies, vaccine efficacy in comorbid populations, and adaptive immunization strategies. Building research capacity and fostering international collaborations are essential for improving vaccination outcomes in older adults across LAC.en
dc.description.affiliationAcademia Latinoamericana de Medicina del Adulto Mayor—ALMA
dc.description.affiliationFacultad de Medicina Centro de Investigación del Envejecimiento Universidad de San Martín de Porres
dc.description.affiliationCHANGE Research Working Group Carrera de Medicina Humana Universidad Científica del Sur
dc.description.affiliationInstituto de Envejecimiento Facultad de Medicina Pontifica Universidad de Javeriana
dc.description.affiliationHospital Dr. Gustavo Fricke Universidad de Valparaíso, Viña del Mar 2362804
dc.description.affiliationFacultad de Medicina Pontificia Universidad Católica del Ecuador, Quito
dc.description.affiliationMedical School of Botucatu São Paulo State University
dc.description.affiliationGrupo NEMECS: Neurociencias Metabolismo Efectividad Clínica y Sanitaria Carrera de Medicina Humana Universidad Científica del Sur
dc.description.affiliationInstituto Nacional de Geriatría, 10200 Ciudad de México
dc.description.affiliationUnespMedical School of Botucatu São Paulo State University
dc.identifierhttp://dx.doi.org/10.3390/vaccines13030240
dc.identifier.citationVaccines, v. 13, n. 3, 2025.
dc.identifier.doi10.3390/vaccines13030240
dc.identifier.issn2076-393X
dc.identifier.scopus2-s2.0-105001110938
dc.identifier.urihttps://hdl.handle.net/11449/298474
dc.language.isoeng
dc.relation.ispartofVaccines
dc.sourceScopus
dc.subjectbibliometric analysis
dc.subjectCOVID-19
dc.subjectinfluenza
dc.subjectLatin America
dc.subjectolder adults
dc.subjectpneumococcal
dc.subjectrespiratory vaccines
dc.titleRespiratory Vaccines in Older Adults: A Bibliometric Analysis and Future Research Agendaen
dc.typeResenhapt
dspace.entity.typePublication
relation.isOrgUnitOfPublicationa3cdb24b-db92-40d9-b3af-2eacecf9f2ba
relation.isOrgUnitOfPublication.latestForDiscoverya3cdb24b-db92-40d9-b3af-2eacecf9f2ba
unesp.author.orcid0000-0002-0336-0584[1]
unesp.author.orcid0000-0003-4045-0260[2]
unesp.author.orcid0000-0001-5680-7880[3]
unesp.author.orcid0000-0002-0186-5992[4]
unesp.author.orcid0000-0001-9876-3222[6]
unesp.author.orcid0000-0002-9728-6644[9]
unesp.campusUniversidade Estadual Paulista (UNESP), Faculdade de Medicina, Botucatupt

Arquivos